Filing Details

Accession Number:
0001209191-18-024125
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-05 18:08:59
Reporting Period:
2018-04-03
Accepted Time:
2018-04-05 18:08:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1035354 Eloxx Pharmaceuticals Inc. ELOX Services-Commercial Physical & Biological Research (8731) 841368850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1726027 Gilad Shabtai C/O Eloxx Pharmaceuticals, Inc.
950 Winter Street, 4Th Floor North
Waltham MA 02451
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-04-03 5,700 $9.41 3,274,170 No 4 P Direct
Common Stock Acquisiton 2018-04-04 2,600 $9.58 3,276,770 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.39 to $9.413, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.50 to $9.69666, inclusive.